1.2949
0.22%
-0.0051
전일 마감가:
$1.30
열려 있는:
$1.32
하루 거래량:
1.11M
시가총액:
$906.09M
수익:
$863.49M
순이익/손실:
$-188.86M
주가수익비율:
-4.7959
EPS:
-0.27
순현금흐름:
$-44.47M
1주 성능:
+2.95%
1개월 성능:
-3.91%
6개월 성능:
-3.91%
1년 성능:
-15.22%
Opko Health Inc Stock (OPK) Company Profile
명칭
Opko Health Inc
전화
305-575-4100
주소
4400 Biscayne Boulevard, Miami, FL
Opko Health Inc Stock (OPK) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-06-29 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
2022-12-15 | 개시 | H.C. Wainwright | Buy |
2022-01-24 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
2021-06-21 | 개시 | Ladenburg Thalmann | Buy |
2019-11-25 | 개시 | Piper Jaffray | Overweight |
2018-03-02 | 다운그레이드 | JP Morgan | Neutral → Underweight |
2017-09-14 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2016-06-21 | 재확인 | Standpoint Research | Buy |
2016-06-03 | 개시 | Standpoint Research | Buy |
2016-03-31 | 재확인 | Barrington Research | Outperform |
2015-10-16 | 개시 | JP Morgan | Overweight |
2015-09-11 | 다운그레이드 | Jefferies | Buy → Hold |
2015-03-03 | 다운그레이드 | Oppenheimer | Outperform → Perform |
2014-05-12 | 재확인 | Oppenheimer | Outperform |
2014-03-14 | 개시 | Oppenheimer | Outperform |
2013-11-13 | 재확인 | Ladenburg Thalmann | Buy |
2013-05-30 | 재확인 | Ladenburg Thalmann | Buy |
2012-10-22 | 개시 | Barrington Research | Outperform |
2011-12-01 | 재확인 | Ladenburg Thalmann | Buy |
2011-07-14 | 개시 | Ladenburg Thalmann | Buy |
모두보기
Opko Health Inc 주식(OPK)의 최신 뉴스
OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024
GlobeNewswire Inc.
OPKO Health (OPK) to Restructure After Asset Buyout by Labcorp
Zacks Investment Research
Critical Insights From OPKO Health Analyst Ratings: What You Need To Know
Benzinga
Labcorp (LH) to Boost Clinical Diagnostics With New Deal
Zacks Investment Research
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday
Benzinga
Opko Health Inc (OPK) 재무 분석
Opko Health Inc (OPK) 매출 2024
OPK은 2023-12-31 종료 분기에 대해 매출(지난 12개월)이 863.49M 달러로 보고했으며, 전년대비 -14.01% 감소했습니다.
Opko Health Inc (OPK) 순이익 2024
OPK은 2023-12-31 종료 분기에 대해 순이익(지난 12개월)이 -188.86M 달러로 보고했으며, 전년대비 +42.49% 증가했습니다.
Opko Health Inc (OPK) 현금흐름 2024
2023-12-31 종료 분기에 OPK은 현금흐름(지난 12개월)으로 -44.47M 달러를 기록했으며, 전년 대비 +62.87% 증가했습니다.
Opko Health Inc (OPK) 주당 순이익 2024
OPK이 보고한 2023-12-31 종료 분기의 주당 순이익(지난 12개월)은 -0.25달러이며, 전년 대비 +43.18% 성장했습니다.
Opko Health Inc 주식 (OPK) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 14 '24 |
Buy |
0.89 |
500,000 |
444,300 |
210,468,225 |
FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 13 '24 |
Buy |
0.93 |
500,000 |
463,750 |
209,968,225 |
FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 12 '24 |
Buy |
0.93 |
600,000 |
559,380 |
209,468,225 |
FROST PHILLIP MD ET AL | CEO & Chairman |
Feb 28 '24 |
Buy |
0.99 |
500,000 |
496,150 |
208,868,225 |
FROST PHILLIP MD ET AL | CEO & Chairman |
Feb 21 '24 |
Buy |
0.99 |
1,000,000 |
991,700 |
208,368,225 |
FROST PHILLIP MD ET AL | CEO & Chairman |
Feb 07 '24 |
Buy |
0.98 |
1,500,000 |
1,462,800 |
207,368,225 |
KRASNO RICHARD M | Director |
Jan 29 '24 |
Buy |
0.99 |
30,000 |
29,838 |
103,333 |
FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 19 '24 |
Buy |
0.98 |
500,000 |
488,650 |
205,868,225 |
FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 18 '24 |
Buy |
0.97 |
400,000 |
386,200 |
205,368,225 |
HSIAO JANE PH D | Vice Chairman & CTO |
Jan 17 '24 |
Buy |
0.95 |
150,000 |
142,500 |
27,999,880 |
자본화:
|
볼륨(24시간):